BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS)
|
|
- CAS-Nr.
- 2240-28-0
- Englisch Name:
- BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS)
- Synonyma:
- 21-Valeratebetamethasone;Betamethasone 21-valerate CRS;Betamethasone impurity E (PhEur);Cocaine Hydrochloride Impurity 6;Betamethasone Valerate Impurity E;Betamethasone Valerate EP Impurity E;Betamethasone Related Compound A (USP);BetaMethasone Valerate Related CoMpound A;Drug impurities Betamethasone 21-valerate;Betamethasone Valerate USP Related Compound A
- CBNumber:
- CB7501384
- Summenformel:
- C27H37FO6
- Molgewicht:
- 476.58
- MOL-Datei:
- 2240-28-0.mol
|
BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS) Eigenschaften
- Siedepunkt:
- 607.5±55.0 °C(Predicted)
- Dichte
- 1.24±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- pka
- 11.99±0.70(Predicted)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher |
T |
|
|
R-Sätze: |
60-61-48 |
|
|
S-Sätze: |
53-45 |
|
|
WGK Germany |
3 |
|
|
HS Code |
2937220000 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H373 |
Kann die Organe schädigen bei längerer oder wiederholter Exposition. |
Spezifische Zielorgan-Toxizität (wiederholte Exposition) |
Kategorie 2 |
Warnung |
|
P260, P314, P501 |
|
Sicherheit |
P202 |
Vor Gebrauch alle Sicherheitshinweise lesen und verstehen. |
P260 |
Dampf/Aerosol/Nebel nicht einatmen. |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P308+P313 |
BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen. |
P405 |
Unter Verschluss aufbewahren. |
P501 |
Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS) Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Betamethasone 21-Valerate is an isomeric impurity of Betamethasone 17-Valerate (B327075), as an corticosteroid. Betamethasone 21-Valerate was generated in the stress study of the active drug Betamethasone 17-Valerate (B327075).
BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 58)Lieferanten
2240-28-0()Verwandte Suche:
- BetaMethasone Valerate Related CoMpound A
- BETAMETHASONE VALERATE RELATED COMPOUND A (50 MG) (BETAMETHASONE 21-VALERATE) (AS)
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(1-oxopentyl)oxy-, (11.beta.,16.beta.)-
- Betamethasone impurity E (PhEur)
- Betamethasone Related Compound A (USP)
- Betamethasone Valerate impurity 4/Betamethasone Valerate EP Impurity E/Betamethasone 21-Valerate
- Betamethasone Valerate Impurity E
- Betamethasone Valerate EP Impurity E
- Betamethasone Valerate EP Impurity E (Betamethasone 21-Valerate)
- Betamethasone 21-valerate CRS
- Betamethasone-21-valerateQ: What is
Betamethasone-21-valerate Q: What is the CAS Number of
Betamethasone-21-valerate Q: What is the storage condition of
Betamethasone-21-valerate Q: What are the applications of
Betamethasone-21-valerate
- Betamethasone Valerate Related Compound A (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopre (1069018)
- Betamethasone Valerate USP Related Compound A
- Betamethasone Valerate Impurity 5 (Betamethasone Valerate EP Impurity E)
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxopentyl)oxy]-, (11β,16β)-
- 1, 4-PREGNADIEN-9α-FLUORO-16β-METHYL-11β, 17, 21-TRIOL-3, 20-DIONE 21-VALERATE
- Drug impurities Betamethasone 21-valerate
- 21-Valeratebetamethasone
- BETAMETHASONE 21-VALERATE /BETAMETHASONE VALERATE RC A
- Cocaine Hydrochloride Impurity 6
- 2240-28-0
- Pharmaceuticals, Intermediates & Fine Chemicals, Steroids